Your browser doesn't support javascript.
loading
APASL-ACLF Research Consortium-Artificial Intelligence (AARC-AI) model precisely predicts outcomes in acute-on-chronic liver failure patients.
Verma, Nipun; Choudhury, Ashok; Singh, Virendra; Duseja, Ajay; Al-Mahtab, Manum; Devarbhavi, Harshad; Eapen, Chundamannil E; Goel, Ashish; Ning, Qin; Duan, Zhongping; Hamid, Saeed; Jafri, Wasim; Butt, Amna Shubhan; Shukla, Akash; Tan, Soek-Siam; Kim, Dong Joon; Hu, Jinhua; Sood, Ajit; Goel, Omesh; Midha, Vandana; Ghaznian, Hashmik; Sahu, Manoj Kumar; Lee, Guan Huei; Treeprasertsuk, Sombat; Shah, Samir; Lesmana, Laurentius A; Lesmana, Rinaldi C; Prasad, V G Mohan; Sarin, Shiv K.
Afiliação
  • Verma N; Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Choudhury A; Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.
  • Singh V; Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Duseja A; Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Al-Mahtab M; Department of Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.
  • Devarbhavi H; Department of Hepatology, St John Medical College, Bangalore, India.
  • Eapen CE; Department of Hepatology, CMC, Vellore, India.
  • Goel A; Department of Hepatology, CMC, Vellore, India.
  • Ning Q; Institute and Department of Infectious Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Duan Z; Translational Hepatology Institute Capital Medical University, Beijing You'an Hospital, Beijing, China.
  • Hamid S; Department of Medicine, Aga Khan University Hospital, Karachi, Pakistan.
  • Jafri W; Department of Medicine, Aga Khan University Hospital, Karachi, Pakistan.
  • Butt AS; Department of Medicine, Aga Khan University Hospital, Karachi, Pakistan.
  • Shukla A; Department of Gastroenterology, Lokmanya Tilak Municipal General Hospital, and Lokmanya Tilak Municipal Medical College, Mumbai, India.
  • Tan SS; Department of Medicine, Hospital Selayang, Selangor, Malaysia.
  • Kim DJ; Department of Internal Medicine, Hallym University College of Medicine, Seoul, South Korea.
  • Hu J; Department of Medicine, 302 Military Hospital, Beijing, China.
  • Sood A; Department of Gastroenterology, DMC, Ludhiana, India.
  • Goel O; Department of Gastroenterology, DMC, Ludhiana, India.
  • Midha V; Department of Gastroenterology, DMC, Ludhiana, India.
  • Ghaznian H; Department of Hepatology, Nork Clinical Hospital of Infectious Disease, Yerevan, Armenia.
  • Sahu MK; Department of Gastroenterology and Hepatology Sciences, IMS & SUM Hospital, Bhubaneswar, India.
  • Lee GH; Division of Gastroenterology and Hepatology, Department of Medicine, National University Health System, Singapore, Singapore.
  • Treeprasertsuk S; Department of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Shah S; Global Hospitals, Mumbai, India.
  • Lesmana LA; Digestive Disease and GI Oncology Centre, Medistra Hospital, Jakarta, Indonesia.
  • Lesmana RC; Digestive Disease and GI Oncology Centre, Medistra Hospital, Jakarta, Indonesia.
  • Prasad VGM; Department of Gastroenterology, VGM Hospital, Coimbatore, India.
  • Sarin SK; Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.
Liver Int ; 43(2): 442-451, 2023 Feb.
Article em En | MEDLINE | ID: mdl-35797245
BACKGROUND AND AIMS: We hypothesized that artificial intelligence (AI) models are more precise than standard models for predicting outcomes in acute-on-chronic liver failure (ACLF). METHODS: We recruited ACLF patients between 2009 and 2020 from APASL-ACLF Research Consortium (AARC). Their clinical data, investigations and organ involvement were serially noted for 90-days and utilized for AI modelling. Data were split randomly into train and validation sets. Multiple AI models, MELD and AARC-Model, were created/optimized on train set. Outcome prediction abilities were evaluated on validation sets through area under the curve (AUC), accuracy, sensitivity, specificity and class precision. RESULTS: Among 2481 ACLF patients, 1501 in train set and 980 in validation set, the extreme gradient boost-cross-validated model (XGB-CV) demonstrated the highest AUC in train (0.999), validation (0.907) and overall sets (0.976) for predicting 30-day outcomes. The AUC and accuracy of the XGB-CV model (%Δ) were 7.0% and 6.9% higher than the standard day-7 AARC model (p < .001) and 12.8% and 10.6% higher than the day 7 MELD for 30-day predictions in validation set (p < .001). The XGB model had the highest AUC for 7- and 90-day predictions as well (p < .001). Day-7 creatinine, international normalized ratio (INR), circulatory failure, leucocyte count and day-4 sepsis were top features determining the 30-day outcomes. A simple decision tree incorporating creatinine, INR and circulatory failure was able to classify patients into high (~90%), intermediate (~60%) and low risk (~20%) of mortality. A web-based AARC-AI model was developed and validated twice with optimal performance for 30-day predictions. CONCLUSIONS: The performance of the AARC-AI model exceeds the standard models for outcome predictions in ACLF. An AI-based decision tree can reliably undertake severity-based stratification of patients for timely interventions.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Insuficiência Hepática Crônica Agudizada Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Insuficiência Hepática Crônica Agudizada Idioma: En Ano de publicação: 2023 Tipo de documento: Article